Lilly begins first clinical trial of antibody that targets SARS-CoV-2
Monday, June 1, 2020 - 18:00
in Health & Medicine
The antibody, isolated by the Canadian start-up AbCellera, was discovered and developed in just 3 months
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via